Cargando…

Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study

Objectives To determine the accuracy and acceptability to patients of non-endoscopic screening for Barrett’s oesophagus, using an ingestible oesophageal sampling device (Cytosponge) coupled with immunocytochemisty for trefoil factor 3. Design Prospective cohort study. Setting 12 UK general practices...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadri, Sudarshan R, Lao-Sirieix, Pierre, O’Donovan, Maria, Debiram, Irene, Das, Madhumita, Blazeby, Jane M, Emery, Jon, Boussioutas, Alex, Morris, Helen, Walter, Fiona M, Pharoah, Paul, Hardwick, Richard H, Fitzgerald, Rebecca C
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938899/ https://www.ncbi.nlm.nih.gov/pubmed/20833740 http://dx.doi.org/10.1136/bmj.c4372

Ejemplares similares

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)

Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux
por: Offman, Judith, et al.
Publicado: (2018)

Gastro-Esophageal Reflux Disease Symptoms and Demographic Factors as a Pre-Screening Tool for Barrett’s Esophagus
por: Liu, Xinxue, et al.
Publicado: (2014)

The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus
por: di Pietro, Massimiliano, et al.
Publicado: (2015)

Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study
por: Freeman, Madeleine, et al.
Publicado: (2017)

Screening for Barrett’s Oesophagus: Are We Ready for it?
por: Yusuf, Aisha, et al.
Publicado: (2021)

Real-world implementation of non-endoscopic triage testing for Barrett’s oesophagus during COVID-19
por: Landy, R, et al.
Publicado: (2023)

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia
por: Januszewicz, Wladyslaw, et al.
Publicado: (2022)

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
por: Fitzgerald, Rebecca C, et al.
Publicado: (2020)

Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020)

Management of Barrett's oesophagus
por: Mannath, Jayan, et al.
Publicado: (2009)

Diet and risk of Barrett’s oesophagus: Melbourne collaborative cohort study
por: Wang, Sabrina E., et al.
Publicado: (2023)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning
por: Berman, Adam G., et al.
Publicado: (2022)

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot
por: Pilonis, Nastazja Dagny, et al.
Publicado: (2022)

Diagnosis and management of Barrett’s oesophagus
por: Jankowski, Janusz, et al.
Publicado: (2010)

The metaplastic mosaic of Barrett’s oesophagus
por: Biswas, Sujata, et al.
Publicado: (2018)

Barrett’s oesophagus: Current controversies
por: Amadi, Chidi, et al.
Publicado: (2017)

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus
por: Luebeck, Jens, et al.
Publicado: (2023)

Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016)

Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020)

Screening for Barrett's oesophagus: is now the time?
por: Hanada, Yuri, et al.
Publicado: (2020)

Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002)

Influence of Life Style Factors on Barrett's Oesophagus
por: Horna Strand, A., et al.
Publicado: (2014)

Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011)

Application of a multi‐gene next‐generation sequencing panel to a non‐invasive oesophageal cell‐sampling device to diagnose dysplastic Barrett's oesophagus
por: Katz‐Summercorn, Annalise, et al.
Publicado: (2017)

Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023)

Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?
por: O’Donovan, Maria, et al.
Publicado: (2018)

Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003)

Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia
por: di Pietro, Massimiliano, et al.
Publicado: (2018)

Does laparoscopic Nissen fundoplication prevent the progression of Barrett’s oesophagus? Is the length of Barrett’s a factor?
por: Bamehriz, Fahad, et al.
Publicado: (2005)

Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study
por: Offman, Judith, et al.
Publicado: (2021)

Barrett’s oesophagus: Is there a need for laparoscopic anti-reflux surgery?
por: Sarela, Abeezar I.
Publicado: (2005)

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
por: Fisher, O M, et al.
Publicado: (2015)

The Role of Quantitative Pathology in Clinical Decision Making for Barrett’s Oesophagus
por: Polkowski, Wojciech, et al.
Publicado: (2003)

Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus
por: Martinez, Pierre, et al.
Publicado: (2016)

Genetic susceptibility to Barrett’s oesophagus: Lessons from early studies
por: Findlay, John M, et al.
Publicado: (2015)

The prevalence of, and risk factors for, Barrett’s oesophagus after sleeve gastrectomy
por: Migaczewski, Marcin, et al.
Publicado: (2021)

Optical Biopsy of Dysplasia in Barrett’s Oesophagus Assisted by Artificial Intelligence
por: van der Laan, Jouke J. H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vkupfgalfgviuoh9fv1vt2gil4